Avantor Free Cash Flow 2018-2024 | AVTR
Avantor annual/quarterly free cash flow history and growth rate from 2018 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Avantor free cash flow for the quarter ending September 30, 2024 was 546.20, a year-over-year.
- Avantor free cash flow for the twelve months ending September 30, 2024 was , a year-over-year.
- Avantor annual free cash flow for 2023 was $0.724B, a 1.89% increase from 2022.
- Avantor annual free cash flow for 2022 was $0.71B, a 15.7% decline from 2021.
- Avantor annual free cash flow for 2021 was $0.843B, a 2.96% decline from 2020.
| Avantor Annual Free Cash Flow | |
|---|---|
| 2023 | 723.60 |
| 2022 | 710.20 |
| 2021 | 842.50 |
| 2020 | 868.20 |
| 2019 | 302.40 |
| 2018 | 162.80 |
| 2017 | -192.70 |
| Avantor Quarterly Free Cash Flow | |
|---|---|
| 2024-09-30 | 546.20 |
| 2024-06-30 | 342.20 |
| 2024-03-31 | 106.90 |
| 2023-12-31 | 723.60 |
| 2023-09-30 | 522.60 |
| 2023-06-30 | 329.60 |
| 2023-03-31 | 191.50 |
| 2022-12-31 | 710.20 |
| 2022-09-30 | 538.20 |
| 2022-06-30 | 318.90 |
| 2022-03-31 | 127.70 |
| 2021-12-31 | 842.50 |
| 2021-09-30 | 581.50 |
| 2021-06-30 | 352.20 |
| 2021-03-31 | 111.80 |
| 2020-12-31 | 868.20 |
| 2020-09-30 | 582.40 |
| 2020-06-30 | 316.20 |
| 2020-03-31 | 240.50 |
| 2019-12-31 | 302.40 |
| 2019-09-30 | 227.50 |
| 2019-06-30 | 42.70 |
| 2019-03-31 | 62.60 |
| 2018-12-31 | |
| 2018-09-30 | 98.30 |
| 2018-06-30 | -0.70 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.184B | $6.967B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.018B | 11.91 |
| Cencora (COR) | United States | $46.162B | 17.64 |
| DiDi Global (DIDIY) | China | $23.816B | 0.00 |
| ICON (ICLR) | Ireland | $18.182B | 16.19 |
| Natera (NTRA) | United States | $15.356B | 0.00 |
| Revvity (RVTY) | United States | $14.929B | 26.14 |
| Viatris (VTRS) | United States | $13.870B | 4.23 |
| BioMerieux (BMXMF) | France | $12.753B | 0.00 |
| Solventum (SOLV) | United States | $12.515B | 0.00 |
| CochLear (CHEOY) | Australia | $12.315B | 0.00 |
| Medpace Holdings (MEDP) | United States | $9.932B | 27.98 |
| Charles River Laboratories (CRL) | United States | $9.343B | 17.66 |
| Sonic Healthcare (SKHHY) | Australia | $8.376B | 0.00 |
| Doximity (DOCS) | United States | $7.863B | 49.82 |
| HealthEquity (HQY) | United States | $7.539B | 40.92 |
| Bausch + Lomb (BLCO) | Canada | $7.221B | 33.62 |
| PACS (PACS) | United States | $6.544B | 0.00 |
| Life Times (LTH) | United States | $4.665B | 30.88 |
| Organon (OGN) | United States | $4.653B | 4.69 |
| Sotera Health (SHC) | United States | $4.492B | 22.66 |
| Surgery Partners (SGRY) | United States | $3.655B | 40.49 |
| BrightSpring Health Services (BTSG) | United States | $2.958B | 63.89 |
| Concentras Parent (CON) | United States | $2.542B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.527B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.482B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.349B | 88.43 |
| GeneDx Holdings (WGS) | United States | $2.094B | 0.00 |
| Premier (PINC) | United States | $2.032B | 9.14 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.922B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.586B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.402B | 7.04 |
| Progyny (PGNY) | United States | $1.354B | 23.81 |
| Pediatrix Medical (MD) | United States | $1.306B | 12.78 |
| Establishment Labs Holdings (ESTA) | $1.269B | 0.00 | |
| CareDx (CDNA) | United States | $1.194B | 0.00 |
| Agilon Health (AGL) | United States | $1.111B | 0.00 |
| Embecta (EMBC) | United States | $0.822B | 5.48 |
| InnovAge Holding (INNV) | United States | $0.803B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 0.00 |
| SBC Medicals (SBC) | United States | $0.707B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.505B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.470B | 0.00 |
| DocGo (DCGO) | United States | $0.371B | 13.96 |
| Enhabit (EHAB) | United States | $0.365B | 31.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.325B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| ModivCare (MODV) | United States | $0.230B | 7.32 |
| Beauty Health (SKIN) | United States | $0.206B | 0.00 |
| Biodesix (BDSX) | United States | $0.189B | 0.00 |
| LifeMD (LFMD) | United States | $0.186B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.184B | 0.00 |
| MultiPlan (MPLN) | United States | $0.148B | 0.00 |
| Nutex Health (NUTX) | United States | $0.114B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.53 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| OncoCyte (OCX) | United States | $0.051B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.69 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.037B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |